Literature DB >> 24638011

Diagnostic challenges of clonal heterogeneity in prostate cancer.

Michael C Haffner1, Angelo M De Marzo2, Srinivasan Yegnasubramanian1, Jonathan I Epstein2, H Ballentine Carter3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24638011     DOI： 10.1200/JCO.2013.50.3540

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  20 in total

Review 1.  [Is there still a role for active surveillance in prostate cancer?]

Authors:  M Stöckle
Journal:  Urologe A       Date:  2017-09       Impact factor: 0.639

Review 2.  Genomic and phenotypic heterogeneity in prostate cancer.

Authors:  Michael C Haffner; Wilbert Zwart; Martine P Roudier; Lawrence D True; William G Nelson; Jonathan I Epstein; Angelo M De Marzo; Peter S Nelson; Srinivasan Yegnasubramanian
Journal:  Nat Rev Urol       Date:  2020-12-16       Impact factor: 14.432

3.  Molecular heterogeneity of localized prostate cancer: more different than alike.

Authors:  Jeffrey J Tosoian; Emmanuel S Antonarakis
Journal:  Transl Cancer Res       Date:  2017-02       Impact factor: 1.241

4.  Long-Term Control of Oligometastatic Prostate Cancer After Stereotactic Body Radiotherapy in the Absence of Androgen Deprivation Therapy: A Case Report.

Authors:  Mark C Markowski; Philip Imus; Jean L Wright; Douglas Schottenstein; Channing J Paller
Journal:  Clin Genitourin Cancer       Date:  2017-02-27       Impact factor: 2.872

5.  Rapid research autopsy is a stealthy but growing contributor to cancer research.

Authors:  Eleonora Duregon; Jowaly Schneider; Angelo M DeMarzo; Jody E Hooper
Journal:  Cancer       Date:  2019-05-15       Impact factor: 6.860

6.  Prostate Cancer Risk Stratification via Nondestructive 3D Pathology with Deep Learning-Assisted Gland Analysis.

Authors:  Weisi Xie; Nicholas P Reder; Can Koyuncu; Patrick Leo; Sarah Hawley; Hongyi Huang; Chenyi Mao; Nadia Postupna; Soyoung Kang; Robert Serafin; Gan Gao; Qinghua Han; Kevin W Bishop; Lindsey A Barner; Pingfu Fu; Jonathan L Wright; C Dirk Keene; Joshua C Vaughan; Andrew Janowczyk; Adam K Glaser; Anant Madabhushi; Lawrence D True; Jonathan T C Liu
Journal:  Cancer Res       Date:  2021-12-01       Impact factor: 13.312

Review 7.  Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications.

Authors:  Qu Deng; Dean G Tang
Journal:  Endocr Relat Cancer       Date:  2015-08-18       Impact factor: 5.678

8.  Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas.

Authors:  Harrison Tsai; Carlos L Morais; Mohammed Alshalalfa; Hsueh-Li Tan; Zaid Haddad; Jessica Hicks; Nilesh Gupta; Jonathan I Epstein; George J Netto; William B Isaacs; Jun Luo; Rohit Mehra; Robert L Vessella; R Jeffrey Karnes; Edward M Schaeffer; Elai Davicioni; Angelo M De Marzo; Tamara L Lotan
Journal:  Clin Cancer Res       Date:  2015-08-05       Impact factor: 12.531

9.  Transcriptomic heterogeneity in multifocal prostate cancer.

Authors:  Simpa S Salami; Daniel H Hovelson; Jeremy B Kaplan; Romain Mathieu; Aaron M Udager; Nicole E Curci; Matthew Lee; Komal R Plouffe; Lorena Lazo de la Vega; Martin Susani; Nathalie Rioux-Leclercq; Daniel E Spratt; Todd M Morgan; Matthew S Davenport; Arul M Chinnaiyan; Joanna Cyrta; Mark A Rubin; Shahrokh F Shariat; Scott A Tomlins; Ganesh S Palapattu
Journal:  JCI Insight       Date:  2018-11-02

Review 10.  Harnessing non-destructive 3D pathology.

Authors:  Jonathan T C Liu; Adam K Glaser; Kaustav Bera; Lawrence D True; Nicholas P Reder; Kevin W Eliceiri; Anant Madabhushi
Journal:  Nat Biomed Eng       Date:  2021-02-15       Impact factor: 25.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.